| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 146.24B | 147.57B | 142.99B | 143.04B | 115.58B | 103.25B |
| Gross Profit | 30.38B | 30.68B | 28.01B | 30.14B | 26.15B | 25.18B |
| EBITDA | 10.96B | 14.35B | 14.87B | 15.55B | 13.59B | 15.38B |
| Net Income | 4.49B | 5.96B | 6.17B | 8.59B | 5.89B | 7.12B |
Balance Sheet | ||||||
| Total Assets | 141.32B | 141.53B | 136.31B | 126.65B | 121.27B | 107.83B |
| Cash, Cash Equivalents and Short-Term Investments | 18.93B | 16.86B | 21.66B | 23.55B | 29.25B | 25.66B |
| Total Debt | 22.29B | 18.86B | 11.57B | 12.62B | 14.55B | 14.09B |
| Total Liabilities | 47.05B | 47.22B | 41.25B | 39.99B | 39.37B | 32.34B |
| Stockholders Equity | 94.26B | 94.31B | 95.05B | 86.66B | 78.73B | 72.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.98B | 2.04B | -128.00M | 5.39B | 13.18B |
| Operating Cash Flow | 0.00 | 13.68B | 12.01B | 6.70B | 9.02B | 16.25B |
| Investing Cash Flow | 0.00 | -20.91B | -10.37B | -5.94B | -4.32B | -2.23B |
| Financing Cash Flow | 0.00 | 3.19B | -5.77B | -8.30B | -2.99B | -3.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥64.28B | 13.15 | ― | 3.33% | 3.03% | 28.27% | |
77 Outperform | ¥86.29B | 17.22 | 10.57% | 1.77% | 15.12% | 40.72% | |
76 Outperform | ¥70.48B | 5.97 | ― | 3.14% | 1.57% | -33.97% | |
74 Outperform | ¥106.40B | 7.64 | ― | 4.71% | 1.16% | 167.89% | |
68 Neutral | ¥65.88B | 14.08 | ― | 3.77% | -0.68% | -9.93% | |
63 Neutral | ¥97.82B | 17.14 | ― | 1.25% | 47.56% | 49.58% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Sumitomo Seika Chemicals Co., Ltd. announced corrections to its previously released consolidated financial results for the year ended March 31, 2025, due to aggregation errors in the data. These corrections are crucial for maintaining accurate financial reporting and transparency, which can impact the company’s credibility and stakeholder trust.
The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals Co., Ltd. has announced a decision by its Board of Directors to acquire up to 210,000 of its own shares, with a maximum expenditure of 1 billion yen, to improve capital efficiency and enhance shareholder returns. This acquisition, set to occur between November 13, 2025, and March 31, 2026, will not impact the company’s financial results for the fiscal year ending March 31, 2026.
The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals Co., Ltd. has revised its full-year consolidated financial forecasts for the fiscal year ending March 31, 2026. While net sales remain unchanged, operating and ordinary profits are expected to increase due to lower raw material costs and a weaker yen against the Chinese yuan. However, profit attributable to owners is projected to decrease due to anticipated business restructuring costs and increased expenses related to customer discussions. The dividend forecast remains unchanged at 100 yen per share.
The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.
Sumitomo Seika Chemicals reported its consolidated financial results for the six months ending September 30, 2025, showing a slight decline in net sales by 1.7% compared to the previous year. Despite this, the company achieved a significant increase in operating profit by 19.9% and ordinary profit by 18.0%, indicating improved operational efficiency. The company also announced plans to acquire treasury shares, which is expected to impact the basic earnings per share forecast for the fiscal year ending March 31, 2026.
The most recent analyst rating on (JP:4008) stock is a Buy with a Yen5423.00 price target. To see the full list of analyst forecasts on Sumitomo Seika Chemicals Co., Ltd. stock, see the JP:4008 Stock Forecast page.